This expert-led webinar will explore the intersection of VTE with cancer, other high-risk conditions, and public health surveillance strategies.
Drs. Alok Khorana and Gary Raskob — both members of NBCA’s Medical and Scientific Advisory Board — will present the latest research and strategies for managing and preventing VTE across diverse patient populations. The presenters will cover the challenges and opportunities in addressing cancer-associated thrombosis, the role of comorbidities in increasing VTE risk, and the evolving landscape of surveillance and preventative care.
Attendees will gain valuable knowledge on integrating evidence-based practices to reduce the burden of VTE on public health systems and individual patients. The discussion is moderated by Dr. Anna Parks, a member of NBCA’s Council of Emerging Researchers in Thrombosis.
Learning Objectives:
- Explore the role of surveillance: Understand the current landscape of VTE surveillance and how it can be used to improve detection and management, with a focus on high-risk populations.
- Describe strategies to address cancer-associated thrombosis: Examine the latest findings and clinical strategies for managing thrombosis in cancer patients.
- Identify risk factors and comorbidities: Learn how conditions such as cardiovascular disease and advanced age contribute to VTE risk and how to mitigate these factors.
- Implement evidence-based practices: Gain practical insights into integrating guidelines and innovative care models to improve VTE outcomes.
Join us for this insightful session to enhance your understanding of VTE, improve patient outcomes, and contribute to broader public health efforts. This webinar is free and requires advance registration here: bit.ly/428maab
For more information, please contact: DBDPHGEvents@cdc.gov
